ReviewEuropean journal of drug metabolism and pharmacokinetics2017

Clinical Pharmacokinetic and Pharmacodynamic Profile of Lenvatinib, an Orally Active, Small-Molecule, Multitargeted Tyrosine Kinase Inhibitor.

Ziad Hussein et al.PubMed ↗Publisher ↗

No numbers read from the abstract.